📰 Retina Division News
Retina Division News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Retina Division. Real-time updates on events, politics, business and more.
June 1, 2023
Healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
April 17, 2023
Retinopathy of prematurity (ROP) that occurs in preterm babies can progress fast, which requires quick decisions early about treatment, explained Darius M. Moshfeghi, MD, chief, Retina Division, and professor at the Horngren Family Vitreoretinal Center, Byers Eye Institute, Department of Ophthalmology, Stanford University School of Medicine.
March 28, 2023
New UCLA research in mice suggests that “dormant” cone photoreceptors in the degenerating retina are not dormant at all, but continue to function, producing responses to light and driving retinal activity for vision.
March 15, 2023
LumiThera Inc., a medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today announced the 24-month data from its LIGHTSITE III, multi-center clinical trial
June 22, 2022
/PRNewswire/ -- LumiThera Inc., a commercial stage medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today...
June 22, 2022
SEATTLE, June 22, 2022 /PRNewswire/ -- LumiThera Inc., a commercial stage medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today announced detailed
May 4, 2022
ISEE earnings call for the period ending March 31, 2022.
May 4, 2022
IVERIC bio, Inc. (NASDAQ:NASDAQ:ISEE) Q1 2022 Earnings Conference Call May 04, 2022, 08:00 AM ET Company Participants Kathy Galante - SVP of IR Glenn Sblendorio - CEO Pravin Dugel -...
March 23, 2022
LumiThera Inc. today announced positive findings in its LIGHTSITE III, multi-center clinical trial in non-neovascular (dry) Age-Related Macular
February 11, 2022
Analysis Further Highlights the Potential for Zimura to Slow the Progression of Disease and Preserve Foveal Anatomy while Sparing the Foveal Center in Patients with GA - IVERIC bio, Inc. (Nasdaq: